| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 2,226 | 0 | 2,226 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| MORGAN STANLEY MED TERM NOTE | 75,000 | 76,313 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| I-SHARES MSCI EMERGING MKT | 60,344 | 77,256 |
| I-SHARES S&P BARRA GROWTH | 88,050 | 173,700 |
| I-SHARES S&P 500 VALUE | 44,884 | 61,971 |
| BARRICK GOLD CORP | 44,930 | 11,070 |
| I SHARES RUSSELL 2000 | 71,590 | 112,620 |
| EDP RENOVAVEIS SA | 58,680 | 47,254 |
| I SHARES LATIN AMERICA 40 | 93,615 | 42,380 |
| I SHARES MSCI CANADA | 52,680 | 43,000 |
| BIOMARIN PHARMACEUTICAL | 60,300 | 104,760 |
| GUARDIAN 8 HOLDINGS | 50,000 | 2,500 |
| SUPERNUS PHARMACEUTICALS | 33,320 | 40,320 |
| MESOBLAST LTD SPON ADR | 78,690 | 79,500 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QCA FIRST FUND IV, LLC | AT COST | 36,385 | 50,000 |
| HEALTHCARE ASSET NETWORK, INC. | AT COST | 60,022 | 60,022 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CUSTODIAN FEES | 86 | 86 | 0 | |
| NON-DEDUCTIBLE EXPENSES FROM QCA FIRST FUND | 5 | 0 | 0 | |
| ORDINARY LOSS - QCA FIRST FUND IV, LLC | 4,010 | 4,010 | 0 | |
| INVESTMENT BAD DEBT | 4,177 | 4,177 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| QCA FIRST FUND IV | 226 | 226 | 226 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| AGENCY & INVESTMENT FEES | 7,029 | 7,029 | 0 | |
| BANK FEES | 20 | 20 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAX PAID | 709 | 709 | 0 |